- Home
- NCZ vs OM Comparison
NCZ vs OM Comparison
Compare NCZ & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCZ
- OM
- Stock Information
- Founded
- NCZ 2003
- OM 2003
- Country
- NCZ United States
- OM United States
- Employees
- NCZ N/A
- OM N/A
- Industry
- NCZ Finance Companies
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NCZ Finance
- OM Health Care
- Exchange
- NCZ Nasdaq
- OM Nasdaq
- Market Cap
- NCZ 228.3M
- OM 247.1M
- IPO Year
- NCZ N/A
- OM 2020
- Fundamental
- Price
- NCZ $13.82
- OM $13.45
- Analyst Decision
- NCZ
- OM Hold
- Analyst Count
- NCZ 0
- OM 1
- Target Price
- NCZ N/A
- OM $22.00
- AVG Volume (30 Days)
- NCZ 533.0K
- OM 154.3K
- Earning Date
- NCZ 01-01-0001
- OM 11-05-2025
- Dividend Yield
- NCZ 12.16%
- OM N/A
- EPS Growth
- NCZ N/A
- OM N/A
- EPS
- NCZ N/A
- OM N/A
- Revenue
- NCZ N/A
- OM $119,304,000.00
- Revenue This Year
- NCZ N/A
- OM $12.37
- Revenue Next Year
- NCZ N/A
- OM $10.52
- P/E Ratio
- NCZ N/A
- OM N/A
- Revenue Growth
- NCZ N/A
- OM 2.47
- 52 Week Low
- NCZ $2.50
- OM $5.85
- 52 Week High
- NCZ $3.15
- OM $25.35
- Technical
- Relative Strength Index (RSI)
- NCZ 77.98
- OM 42.03
- Support Level
- NCZ $13.43
- OM $13.01
- Resistance Level
- NCZ $13.55
- OM $14.22
- Average True Range (ATR)
- NCZ 0.10
- OM 0.62
- MACD
- NCZ 0.03
- OM 0.17
- Stochastic Oscillator
- NCZ 96.05
- OM 30.71
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. The investment objective of the company is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas, and consumable fuels and others.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.